China Fortune Finance and Economics APP News, Zhejiang Dayang Biotech Group (003017.SZ) announced that the company plans to invest in the construction of an annual production capacity of 800 tons of ampicillin relocation and expansion project with self-raised funds of 0.302 billion RMB (same currency).
China Fortune Finance and Economics APP News, Zhejiang Dayang Biotech Group (003017.SZ) announced that the company plans to invest in the construction of an annual production capacity of 800 tons of ampicillin relocation and expansion project with self-raised funds of 0.302 billion RMB (same currency).
This project is a relocation and expansion project. After entering the park, it can significantly improve the safety risks of the current town. It will also help the company expand its business of ampicillin, enhance and extend the company's profitability, and expand its influence in the global ampicillin market. After the smooth completion and production of the project, the company's advantages in ampicillin production capacity and cost will be further enhanced, and the leading edge in this field will help the company occupy a dominant position, which is of great significance for the long-term development of the company's veterinary medicines.
Comment(0)
Reason For Report